BR112014005651A2 - aparelho de diagnóstico - Google Patents

aparelho de diagnóstico

Info

Publication number
BR112014005651A2
BR112014005651A2 BR112014005651A BR112014005651A BR112014005651A2 BR 112014005651 A2 BR112014005651 A2 BR 112014005651A2 BR 112014005651 A BR112014005651 A BR 112014005651A BR 112014005651 A BR112014005651 A BR 112014005651A BR 112014005651 A2 BR112014005651 A2 BR 112014005651A2
Authority
BR
Brazil
Prior art keywords
individual
determining
diagnostic
diagnostic apparatus
physical condition
Prior art date
Application number
BR112014005651A
Other languages
English (en)
Inventor
Moore Brian
Original Assignee
Orreco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orreco Ltd filed Critical Orreco Ltd
Publication of BR112014005651A2 publication Critical patent/BR112014005651A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/06—Investigating concentration of particle suspensions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/491—Blood by separating the blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/492—Determining multiple analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/06—Investigating concentration of particle suspensions
    • G01N15/075—Investigating concentration of particle suspensions by optical means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/016—White blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Ecology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Plasma & Fusion (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

resumo patente de invenção: "aparelho de diagnóstico". a presente invenção refere-se a um aparelho de diagnóstico (1) para analisar uma amostra de sangue, o aparelho compreendendo um luminômetro (9) para a geração de uma "curva de luminescência" e contadores de células brancas do sangue (5, 7) para a determinação de uma contagem de linfócitos e contagem de neutrófilos, e meios de processamento (10) para determinar uma condição física do indivíduo em função da "curva de luminescência" e das contagens de células brancas do sangue. um método de diagnóstico é também descrito, para a determinação da condição física de um indivíduo com base nos dados do teste de sangue. um sistema de diagnóstico é também descrito em que os dados gerados pelos testes de sangue realizados em um local remoto podem ser comunicados a um servidor central (201), onde um resultado de condicionamento pode ser gerado, e, por conseguinte comunicado ao indivíduo ou a uma terceira parte. o servidor também pode armazenar informações complementares a respeito do indivíduo, as quais podem ser feitas acesso aos usuários remotos.
BR112014005651A 2011-09-13 2012-09-12 aparelho de diagnóstico BR112014005651A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1115843.3A GB2494653A (en) 2011-09-13 2011-09-13 Apparatus for blood analysis
PCT/GB2012/000712 WO2013038127A1 (en) 2011-09-13 2012-09-12 Diagnostic apparatus

Publications (1)

Publication Number Publication Date
BR112014005651A2 true BR112014005651A2 (pt) 2017-03-28

Family

ID=44908524

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014005651A BR112014005651A2 (pt) 2011-09-13 2012-09-12 aparelho de diagnóstico

Country Status (10)

Country Link
US (1) US20140234952A1 (pt)
EP (1) EP2756296B1 (pt)
JP (1) JP2014526695A (pt)
KR (1) KR20140063817A (pt)
CN (1) CN104053983A (pt)
AU (1) AU2012307128A1 (pt)
BR (1) BR112014005651A2 (pt)
GB (1) GB2494653A (pt)
WO (1) WO2013038127A1 (pt)
ZA (1) ZA201402224B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013111416A1 (de) * 2013-10-16 2015-04-30 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Verfahren zum Bestimmen zumindest einer physikalischen, chemischen und/oder biologischen Messgröße mittels optischer Sensoren und Trübungssensoren
CN103544401A (zh) * 2013-11-04 2014-01-29 武汉明德生物科技有限责任公司 一种远程试剂检测信息的获取方法、装置及系统
WO2017096138A1 (en) * 2015-12-02 2017-06-08 Def Medical Technologies, Inc. In vivo measurement of cell concentrations in fluid near an implanted medical device
JP6735179B2 (ja) 2016-08-10 2020-08-05 浜松ホトニクス株式会社 測定容器
JP6903494B2 (ja) * 2017-06-09 2021-07-14 シスメックス株式会社 感染症を識別するための粒子分析方法
KR101868346B1 (ko) * 2017-07-28 2018-06-18 주식회사 미코바이오메드 혈액의 광학 측정을 위한 큐벳 장치 및 이를 포함하는 바이오 광학 측정 장치
US20190317048A1 (en) * 2018-04-17 2019-10-17 Illinois Tool Works Inc. Systems and methods to remotely manage non-destructive testing systems
US10976201B2 (en) * 2018-06-25 2021-04-13 Ranzy Morgan, III Liquid color, haze, and clarity instrument, and method of measurement
MX2021015445A (es) * 2019-06-27 2022-04-06 Binary Llc Ensayo de quimioluminiscencia a base de oxidasa de leucocitos fagocitica en sangre entera y en fluidos corporales aplicables a las pruebas de diagnostico de punto de cuidado (poc) la medicion de punto de cuidado (poc) de la funcion neutrofila absoluta (anf).
US11008627B2 (en) * 2019-08-15 2021-05-18 Talis Biomedical Corporation Diagnostic system
CN113495086A (zh) * 2020-04-03 2021-10-12 深圳市帝迈生物技术有限公司 Poct血细胞分析仪及试剂盒
CN113917165A (zh) * 2020-07-10 2022-01-11 深圳市帝迈生物技术有限公司 Poct样本分析仪及其检测方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108899A (en) * 1989-10-31 1992-04-28 Exoxemis, Inc. Chemiluminescence assay of in vivo inflammation
IL132687A0 (en) * 1999-11-01 2001-03-19 Keren Mechkarim Ichilov Pnimit System and method for evaluating body fluid samples
US7553453B2 (en) * 2000-06-02 2009-06-30 Honeywell International Inc. Assay implementation in a microfluidic format
CN1694645A (zh) * 2002-08-09 2005-11-09 松下电器产业株式会社 数据测定装置和健康管理数据的获取系统及获取方法
CN101379404A (zh) * 2005-12-22 2009-03-04 霍尼韦尔国际公司 具有活动式盒的血液学分析仪系统
WO2008089282A2 (en) * 2007-01-16 2008-07-24 Silver James H Sensors for detecting subtances indicative of stroke, ischemia, infection or inflammation
EP2055384A1 (de) * 2007-10-31 2009-05-06 Leukocare AG Vorrichtung zum Nachweis von Bestandteilen in einem Fluid
EP2293062B1 (en) * 2008-05-09 2015-01-28 Sysmex Corporation Blood analyzer, blood analysis method, hemolytic agent and staining agent
GB201004239D0 (en) * 2010-03-15 2010-04-28 Knight Scient Ltd Detection of overtraining syndrome in an individual

Also Published As

Publication number Publication date
EP2756296A1 (en) 2014-07-23
AU2012307128A1 (en) 2014-04-10
CN104053983A (zh) 2014-09-17
KR20140063817A (ko) 2014-05-27
JP2014526695A (ja) 2014-10-06
GB2494653A (en) 2013-03-20
EP2756296B1 (en) 2017-11-15
WO2013038127A1 (en) 2013-03-21
US20140234952A1 (en) 2014-08-21
ZA201402224B (en) 2015-10-28
GB201115843D0 (en) 2011-10-26

Similar Documents

Publication Publication Date Title
BR112014005651A2 (pt) aparelho de diagnóstico
Chen et al. Impact of preservation method and 16S rRNA hypervariable region on gut microbiota profiling
Onishi et al. Publication bias is underreported in systematic reviews published in high-impact-factor journals: metaepidemiologic study
Hari et al. Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant
Qin et al. Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials
ES2554993T3 (es) Sistema de análisis para el análisis de muestras biológicas, métodos y producto de programa informático
Shan et al. Diagnostic accuracy of clinical pulmonary infection score for ventilator-associated pneumonia: a meta-analysis
Watkins et al. OCT1 and imatinib transport in CML: is it clinically relevant?
BR112016011084B8 (pt) Dispositivo integrado para analisar uma pluralidade de amostras em paralelo, métodos de análise desta pluralidade de amostras, para a fabricação de uma cavidade de amostra e estrutura ótica alinhada à referida cavidade, de sequenciamento de uma molécula de ácido nucleico e de formação de uma fonte de excitação de escala nano alinhada, e instrumento portátil
Song et al. Associations of low hand grip strength with 1 year mortality of cancer cachexia: a multicentre observational study
BR112017009151A2 (pt) ensaios para detectar subgrupos imunológicos de célula t e métodos de uso dos mesmos
BR112014010718A2 (pt) métodos e sistemas para detecção de analito em amostra
van Enst et al. Meta-epidemiologic analysis indicates that MEDLINE searches are sufficient for diagnostic test accuracy systematic reviews
Anderson et al. Race, ethnicity, and the duration of untreated psychosis: a systematic review
BR112015011359A8 (pt) método para indicar uma presença ou não presença de câncer de próstata agressivo, dispositivo de ensaio, kit de teste, produto de programa de computador, e aparelho
UY30893A1 (es) Metodos y dispositivos para el diagnostico de apendicitis
BR112015014766A2 (pt) sistema e método para identificar veículo por utilizar campo magnético detectado
BR112013032591A2 (pt) método e aparelho para mapear dados da saúde adquiridos pelo menos por um primeiro dispositivo de medição que é inútil por uma pluralidade de usuários em um registro de saúde apropriado e programa de computador em um meio legível por computador
Nielsen et al. Comparison of recording of pericarditis and lung disorders at routine meat inspection with findings at systematic health monitoring in Danish finisher pigs
BR112015008042A2 (pt) diagnósticos complementares para terapia com inibidor de quinase da família tec
Noguchi et al. Obesity, physical activity and bladder cancer
BR112015001639A2 (pt) dispositivo, sistema, método e meio legível por computador de análise universal de teste de diagnóstico rápido de imunoensaio
BRPI0909825B8 (pt) método e sistemas para detecção não-invasiva de glicose sanguíneo utilizando dados espectrais de um ou mais componentes que não a glicose
Qian et al. Expression of nuclear factor, erythroid 2-like 2-mediated genes differentiates tuberculosis
Kaewseekhao et al. Diagnosis of active tuberculosis and latent tuberculosis infection based on Raman spectroscopy and surface-enhanced Raman spectroscopy

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B15I Others concerning applications: loss of priority
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]